BlackRock NURS II Consensus 85 XM
|Bid Price||GBX 126.00||Offer Price||GBX 126.40|
|Mid Price||-||Day Change||GBX +0.70 (0.64%)|
|Price Date||22 May 2017||Crown Rating|
|Shares Class||Inc.||Yield||2.14 %|
|Total Expense Ratio||0.01||Fund Size||8,761,636,743.72|
|Launch Date||19/08/2005||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.00||Sector||IMA UK Equity Income|
|Min Investment (£)||500,000,000.00||Total Expense Ratio (%)||0.01|
|ISIN||GB00BYMT6376||Min TopUp (£)||100.00|
The Fund seeks to achieve a total return for investors. The Fund invests primarily in global collective investments schemes across several asset classes. The Fund may invest in equity or fixed income transferable securities, money-market instruments, deposits and cash and near cash. The Fund will aim to have between 40-85% of its investment exposure in equity securities. Derivatives and forward transactions may be used for the purposes of efficient portfolio management.
Steve Walker, Director and portfolio manager, is a member of the Beta Strategies Group. Within Beta Strategies, Mr. Walker is head of the Index Asset Allocation team in EMEA. Mr. Walker's service with the firm dates back to 2007, including his years with Barclays Global Investors (BGI), which merged with BlackRock in 2009. At BGI, he was a portfolio manager in the Client Solutions team. Prior to joining BGI, Mr. Walker was a portfolio manager in the discretionary investment team at Coutts & Co bank for over 12 years.